
Massachusetts Lawmakers Prioritize Health Policy
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.

Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.

Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
I saw a popup ad on TIE today (see below). This is unacceptable. We do not allow advertising here. But it’s happened before that some
In “Assessing the case for social experiments,” James Heckman and Jeffrey Smith warn against mistaking the apparent simplicity of randomized controlled trials for actual simplicity. For,
Austin and I had an exchange a couple of weeks ago where he expressed frustration at all the bickering about Halbig. Some people think the
From JAMA Internal Medicine, “Cancer Screening Rates in Individuals With Different Life Expectancies“: Importance: Routine cancer screening has unproven net benefit for patients with limited
The following originally appeared on The Upshot (copyright 2014, The New York Times Company). Medicare Advantage plans — private plans that serve as alternatives to the traditional,
About my post on RCT’s gold-standard reputation, below is text of an email from a reader who wishes to remain anonymous. I’m posting it not because
The following is a guest post by Allan Joseph, a medical student at the Warren Alpert Medical School of Brown University and TIE research assistant.
From the New Yorker article today on the economics of Ebola (introducing a new word, Ebolanomics): What people in the West need, health officials agree, is
John Ionnadis and colleagues have a remarkable finding about scientific authors: we estimated that there are 15,153,100 publishing scientists (distinct author identifiers) in the period
In “Instruments, Randomization, and Learning about Development,” Angus Deaton pulls no punches. He’s just as brutal, blunt, and precise about pitfalls and misuse of instrumental variables
Our latest episode is based on a column I wrote for the NYT: The news is full these days of advances in phones and personal
Mark Sullivan over at Venture Beat News:”Guess what? Doctors don’t care about your Fitbit data“: But sources in the medical devices, digital health, and healthcare industries